Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insmed (INSM) Return on Equity (2016 - 2026)

Insmed's Return on Equity history spans 16 years, with the latest figure at 0.02% for Q1 2026.

  • Quarterly Return on Equity rose 4.0% to 0.02% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.02% through Mar 2026, up 4.0% year-over-year, with the annual reading at 0.02% for FY2025, 42.0% down from the prior year.
  • Return on Equity came in at 0.02% for Q1 2026, down from 0.02% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.07% in Q2 2023 to a low of 0.61% in Q3 2022.
  • The 5-year median for Return on Equity is 0.02% (2026), against an average of 0.06%.
  • Year-over-year, Return on Equity plummeted -60bps in 2022 and then soared 64bps in 2023.
  • Insmed's Return on Equity stood at 0.17% in 2022, then surged by 115bps to 0.02% in 2023, then tumbled by -199bps to 0.02% in 2024, then skyrocketed by 36bps to 0.02% in 2025, then decreased by -8bps to 0.02% in 2026.
  • Per Business Quant, the three most recent readings for INSM's Return on Equity are 0.02% (Q1 2026), 0.02% (Q4 2025), and 0.01% (Q3 2025).